// App-Quantinova.ai

882 : Safety of Weight-Adjusted Dosing of LMWH in Clinically Obese Cancer Patients with Venous Thromboembolism

Researchers

Presenter

  • Gillian Mount

Principal Investigators

  • Michael J. Kovacs

  • Alejandro Lazo-Langner

  • Lenicio Siqueira

  • Martha L Louzada

Medical Centers

  • London Health Sciences Center, London, ON, Canada

  • Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB, Canada

  • Department of Medicine, Division of Hematology, London Health Sciences Centre, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Obesity

  • Solid malignancies

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved